Correction to "Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: a Guide for Selective Node Dissection"
Saygin Altiner, Ramazan Kozan, Ahmet Cihangir Emral, Ferit Taneri, Ahmet Karamercan

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
|
|
|
|
|
|
| ||
|
|
|
|
| ||||
| Age group (n = 255) | |||||||
| < 45 years | 71 | 40.1% | 106 | 59.9% | 0.016 | 1.00 | 0.30-0.89 |
| ≥ 45 years | 44 | 56.4% | 34 | 43.6% | 0.52 | ||
| χ2 = 5.808 | |||||||
| Sex (n = 255) | |||||||
| Men | 20 | 32.8% | 41 | 67.2% | 0.027 | 1.97 | 1.07-3.60 |
| Women | 95 | 49.0% | 99 | 51.0% | 1.00 | ||
| χ2 = 4.908 | |||||||
| Intra-thyroidal localization (n = 236) | |||||||
| Superior | 45 | 69.2% | 20 | 30.8% | < 0.001 | 0.13 | 0.06-0.28 |
| Middle | 22 | 48.9% | 23 | 51.1% | 0.29 | 0.13-0.69 | |
| Inferior | 13 | 22.0% | 46 | 78.0% | 1.00 | ||
| Isthmus/junction | 15 | 37.5% | 25 | 62.5% | 0.47 | 0.19-1.14 | |
| Multilobar | 9 | 33.3% | 18 | 66.7% | 0.56 | 0.21-1.55 | |
| χ2 = 30.705 | |||||||
| Tumor subtype (n = 255) | |||||||
| Classic | 80 | 43.2% | 105 | 56.8% | 0.010 | 1.00 | |
| Follicular variant | 30 | 61.2% | 19 | 38.8% | 0.48 | 0.25-0.92 | |
| Others | 5 | 23.8% | 16 | 76.2% | 2.43 | 0.86-6.94 | |
| χ2 = 9.248 | |||||||
| Lymphovascular invasion (n = 255) | |||||||
| No | 99 | 94.3% | 6 | 5.7% | < 0.001 | 1.00 | 52.20-365.83 |
| Yes | 16 | 10.7% | 134 | 89.3% | 138.19 | ||
| χ2 = 174,424 | |||||||
| Extracapsular invasion (n = 255) | |||||||
| No | 114 | 46.9% | 129 | 53.1% | 0.020 | 1.00 | 1.24-76.47 |
| Yes | 1 | 8.3% | 11 | 91.7% | 9.72 | ||
| χ2 = 6.874 | |||||||
|
|
|
|
|
| Age group | 0.09-0.81 | 0.020 | |
| < 45 years | 1.00 | ||
| ≥ 45 years | 0.27 | ||
| Sex | 1.16-15.63 | 0.029 | |
| Men | 4.26 | ||
| Women | 1.00 | ||
| Intra-thyroidal localization | |||
| Superior | 0.39 | 0.09-1.66 | 0.204 |
| Middle | 0.81 | 0.17-3.85 | 0.790 |
| Inferior | 1.00 | ||
| Isthmus/junction | 0.63 | 0.12-3.45 | 0.598 |
| Multilober | 1.17 | 0.20-6.74 | 0.861 |
| Tumor subtype | |||
| Classic | 1.00 | ||
| Follicular variant | 0.17 | 0.05-0.57 | 0.004 |
| Others | 0.58 | 0.06-5.33 | 0.634 |
| Lymphovascular invasion | |||
| No | 1.00 | 65.55-1087.18 | < 0.001 |
| Yes | 266.96 | ||
| Extracapsular invasion | |||
| No | 1.00 | 1.51-737.15 | 0.026 |
| Yes | 33.37 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsThyroid Cancer Diagnosis and Treatment · Radiomics and Machine Learning in Medical Imaging · Thyroid and Parathyroid Surgery
Dear Editor,
We have carefully reviewed the letter regarding our article titled “Effects of Patient and Tumor Characteristics on Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Guide for Selective Node Dissection”.^1^ We sincerely appreciate the valuable comments and attention given by Shahraki HR.^2^
We have re-examined the data set and statistical analyses retrospectively, and we also thoroughly reviewed all the analyses. We acknowledge that there were errors in transferring the results to the tables during the stage of presenting the outcomes associated with the conduct of univariate and multivariate analyses by different individuals. Additionally, we recognize that providing more detailed information in the tables would strengthen the comprehensibility of our study. Consequently, in the multiple logistic regression, we have reported odds ratios for individual categories by accepting one category as the baseline for quantitative variables with more than two categories.
However, it is essential to emphasize that these corrections have not led to any changes in the findings and conclusions of our study.
Below are the revised and detailed Table 2 and Table 3, reflecting the numerical changes in the results of univariate and multivariable analyses. The corrected paragraph in the “Results” section reads as follows:
‘In univariate analysis, the risk of CLNM was shown to be higher in those under 45 years of age than those aged 45 years and above [odds ratio (OR) = 0.52, 95% CI 0.30−0.89, P = 0.016]. Additionally, male gender was associated an elevated risk of CLNM (OR = 1.97, 95% CI 1.07−3.60, P = 0.027). Other risk factors for CLNM were lymphovascular invasion (OR = 138.19, 95% CI 52.20−365.83, P < 0.001) and extracapsular invasion (OR = 9.72, 95% CI 1.24−76.47, P = 0.020). The relationship between histopathological subtypes of the tumor and CLNM was examined, and it was found that the follicular variant subtype had a lower probability of metastasis than the other subtypes (95% CI 0.25−0.92, P = 0.010). When the localization of the tumor in the thyroid lobe was evaluated, it was shown that tumors situated in the superior lobe had a lower probability of CLNM than tumors located in the other lobes (95% CI 0.06−0.28, P < 0.001) (Table 2). There was no relationship between CLNM and whether the tumor was unifocal or multifocal (OR = 1.67, 95% CI 0.99−2.80, P = 0.054). Multivariable analysis revealed that age at diagnosis (OR = 0.27, 95% CI 0.09−0.81, P = 0.020), gender (OR = 4.26, 95% CI 1.16−15.63, P = 0.029), tumor subtype for follicular variant (OR = 0.17, 95% CI 0.05−0.57, P = 0.004), lymphovascular invasion (OR = 266.96, 95% CI 65.55−1087.18, P < 0.001) and extracapsular invasion (OR = 33.37, 95% CI 1.51–737.15, P = 0.026) were statistically significant independent predictive factors. However, intra-thyroidal localization of the tumor was not significant for CLNM (Table 3).’
In conclusion, we believe that the valuable critiques and suggestions provided have enhanced the statistical transparency and accuracy of our study. We recognize the significance of reader engagement in research publications and how it contributes to the advancement of published studies.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Altiner S Kozan R Emral AC Taneri F Karamercan A Effects of patient and tumor characteristics on central lymph node metastasis in papillary thyroid cancer: a guide for selective node dissection Arch Iran Med 20222511730610.34172/aim.2022.11537543897 PMC 10685851 · doi ↗ · pubmed ↗
- 2Shahraki HR Comments on “Effects of patient and tumor characteristics on central lymph node metastasis in papillary thyroid cancer: a guide for selective node dissection”Arch Iran Med 20242785910.34172/aim.2731739306719 · doi ↗ · pubmed ↗
